348 related articles for article (PubMed ID: 9226315)
1. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden.
Wazer DE; Schmidt-Ullrich RK; Schmid CH; Ruthazer R; Kramer B; Safaii H; Graham R
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):291-9. PubMed ID: 9226315
[TBL] [Abstract][Full Text] [Related]
2. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor.
Wazer DE; Schmidt-Ullrich RK; Ruthazer R; DiPetrillo T; Boyle T; Kanski J; Safaii H
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):885-91. PubMed ID: 10571194
[TBL] [Abstract][Full Text] [Related]
3. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.
Neuschatz AC; DiPetrillo T; Steinhoff M; Safaii H; Yunes M; Landa M; Chung M; Cady B; Wazer DE
Cancer; 2002 Apr; 94(7):1917-24. PubMed ID: 11932892
[TBL] [Abstract][Full Text] [Related]
4. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for residual disease in re-excision specimens after breast-conserving surgery.
Atalay C; Irkkan C
Breast J; 2012; 18(4):339-44. PubMed ID: 22616572
[TBL] [Abstract][Full Text] [Related]
6. Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation.
Wazer DE; Jabro G; Ruthazer R; Schmid C; Safaii H; Schmidt-Ullrich RK
Radiat Oncol Investig; 1999; 7(2):111-7. PubMed ID: 10333252
[TBL] [Abstract][Full Text] [Related]
7. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.
Vicini FA; Kestin LL; Goldstein NS
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):722-30. PubMed ID: 15465188
[TBL] [Abstract][Full Text] [Related]
8. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
Smitt MC; Horst K
Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
[TBL] [Abstract][Full Text] [Related]
9. Margin width is not predictive of residual disease on re-excision in breast conserving therapy.
Hadzikadic Gusic L; McGuire KP; Ozmen T; Soran A; Thomas CR; McAuliffe PF; Diego EJ; Bonaventura M; Johnson RR; Ahrendt GM
J Surg Oncol; 2014 Apr; 109(5):426-30. PubMed ID: 24338603
[TBL] [Abstract][Full Text] [Related]
10. Residual disease after re-excision lumpectomy for close margins.
Sabel MS; Rogers K; Griffith K; Jagsi R; Kleer CG; Diehl KA; Breslin TM; Cimmino VM; Chang AE; Newman LA
J Surg Oncol; 2009 Feb; 99(2):99-103. PubMed ID: 19065638
[TBL] [Abstract][Full Text] [Related]
11. Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ.
Laws A; Brar MS; Bouchard-Fortier A; Leong B; Quan ML
J Surg Oncol; 2018 Dec; 118(7):1205-1211. PubMed ID: 30293241
[TBL] [Abstract][Full Text] [Related]
12. Histological margin assessment for breast ductal carcinoma in situ: precision and implications.
Sigal-Zafrani B; Lewis JS; Clough KB; Vincent-Salomon A; Fourquet A; Meunier M; Falcou MC; Sastre-Garau X;
Mod Pathol; 2004 Jan; 17(1):81-8. PubMed ID: 14657957
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic significance of ductal carcinoma in situ in breast core needle biopsies with invasive cancer.
Jimenez RE; Bongers S; Bouwman D; Segel M; Visscher DW
Am J Surg Pathol; 2000 Jan; 24(1):123-8. PubMed ID: 10632496
[TBL] [Abstract][Full Text] [Related]
14. Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions.
Cao D; Lin C; Woo SH; Vang R; Tsangaris TN; Argani P
Am J Surg Pathol; 2005 Dec; 29(12):1625-32. PubMed ID: 16327435
[TBL] [Abstract][Full Text] [Related]
15. Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS.
Fisher CS; Klimberg VS; Khan S; Gao F; Margenthaler JA
Ann Surg Oncol; 2011 Oct; 18(11):3155-9. PubMed ID: 21947593
[TBL] [Abstract][Full Text] [Related]
16. Extent of margin involvement, lymphovascular invasion, and extensive intraductal component predict for residual disease after wide local excision for breast cancer.
Alrahbi S; Chan PM; Ho BC; Seah MD; Chen JJ; Tan EY
Clin Breast Cancer; 2015 Jun; 15(3):219-26. PubMed ID: 25576998
[TBL] [Abstract][Full Text] [Related]
17. Imaging of lumpectomy surface with large field-of-view confocal laser scanning microscope for intraoperative margin assessment - POLARHIS study.
Sandor MF; Schwalbach B; Hofmann V; Istrate SE; Schuller Z; Ionescu E; Heimann S; Ragazzi M; Lux MP
Breast; 2022 Dec; 66():118-125. PubMed ID: 36240525
[TBL] [Abstract][Full Text] [Related]
18. A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgery.
Ward ST; Jones BG; Jewkes AJ
Int J Clin Pract; 2010 Nov; 64(12):1675-80. PubMed ID: 20946273
[TBL] [Abstract][Full Text] [Related]
19. Margin width should not still enforce a systematic surgical re-excision in the conservative treatment of early breast infiltrative ductal carcinoma.
Jaffré I; Campion L; Dejode M; Bordes V; Sagan C; Loussouarn D; Dravet F; Andrieux N; Classe JM
Ann Surg Oncol; 2013 Nov; 20(12):3831-8. PubMed ID: 23838905
[TBL] [Abstract][Full Text] [Related]
20. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed.
Wazer DE; Schmidt-Ullrich RK; Ruthazer R; Schmid CH; Graham R; Safaii H; Rothschild J; McGrath J; Erban JK
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):851-8. PubMed ID: 9531370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
